Neuroprotective effects of icariin in animal models of depression and anxiety: a systematic review of preclinical studies.
📄 Abstract
Icariin, a major bioactive flavonoid extracted from The online version contains supplementary material available at 10.1186/s12906-026-05302-9.
Confidence:
0.09
· 4 полей извлечено
Идентификация (6 полей)
Механизм действия (21 полей)
Mechanism
—
0.00
Mutations (obesity/lean)
—
0.00
Activity (obesity)
—
0.00
Activity temporal
—
0.00
Energy balance
—
0.00
Appetite
—
0.00
Fat metabolism
—
0.00
Lipolysis
—
0.00
Thermogenesis
—
0.00
Muscle metabolism
—
0.00
Inflammation
—
0.00
Glucose metabolism
—
0.00
AA metabolism
—
0.00
Hormonal pathways
—
0.00
Cell death
—
0.00
Adipocyte fibrosis
—
0.00
Upstream (biochem)
—
0.00
Upstream (physiol)
—
0.00
Downstream (biochem)
—
0.00
Downstream (physiol)
—
0.00
PTMs
—
0.00
Экспрессия (8 полей)
Tissue expression
—
0.00
In vitro
—
0.00
In vivo
Icariin was studied in animal models of depression and anxiety; quercetin was studied in a mouse model of dietary advanced glycation end products-induced anxiety- and depression-like behaviors.
0.90
In silico
—
0.00
Genetic association
—
0.00
Ex vivo
—
0.00
Animal model
Animal models of depression and anxiety (icariin); female C57BL/6 mice (quercetin).
0.90
Diet/model
Dietary advanced glycation end products induced anxiety- and depression-like behaviors in female C57BL/6 mice.
0.90
Клиника (11 полей)
Drug
icariin
0.90
Indication
—
0.00
Patient subgroups
—
0.00
Safety concerns
—
0.00
Off-target
—
0.00
Trial stage
—
0.00
Pharma competitors
—
0.00
AE severity
—
0.00
MOA weight loss
—
0.00
Endpoints
—
0.00
Approved
—
0.00